Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 28, 2006; 12(4): 516-519
Published online Jan 28, 2006. doi: 10.3748/wjg.v12.i4.516
Published online Jan 28, 2006. doi: 10.3748/wjg.v12.i4.516
HRS Type 1: Rapidly progressing renal failure (< 2 wk) ≥ 2-fold increase of serum creatinine to > 221μmol/L or 50% decrease of creatinine clearance to < 20mL/min |
HRS Type 2: Not rapidly progressing renal failure |
Serum creatinine > 132.6 μmol/L or |
Creatinine clearance < 40mL/min |
Absence of shock, ongoing bacterial infection, current or recent treatment with nephrotoxic drugs, gastrointestinal or renal fluid loss |
No sustained improvement upon withdrawal of diuretics and plasma volume expansion |
Proteinuria < 0.5g/d, no abnormalities of renal ultrasound |
- Citation: Gerbes AL, Gulberg V. Progress in treatment of massive ascites and hepatorenal syndrome. World J Gastroenterol 2006; 12(4): 516-519
- URL: https://www.wjgnet.com/1007-9327/full/v12/i4/516.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i4.516